4//SEC Filing
Blanchard Cheryl R 4
Accession 0001171843-25-001404
CIK 0000898437other
Filed
Mar 10, 8:00 PM ET
Accepted
Mar 11, 5:17 PM ET
Size
10.4 KB
Accession
0001171843-25-001404
Insider Transaction Report
Form 4
Blanchard Cheryl R
DirectorPresident, CEO, Director
Transactions
- Tax Payment
Common Stock
2025-03-10$16.62/sh−5,871$97,576→ 166,955 total - Exercise/Conversion
Common Stock
2025-03-10+20,002→ 172,826 total - Exercise/Conversion
Restricted Stock Unit
2025-03-10−20,002→ 20,001 totalExercise: $0.00→ Common Stock (20,002 underlying)
Holdings
- 11,742(indirect: By Trust)
Common Stock
Footnotes (6)
- [F1]Reflects the second vesting installment of RSUs granted on March 9, 2023.
- [F2]Includes the following shares acquired under the Anika Therapeutics, Inc. Employee Stock Purchase Plan: 800 shares purchased on May 14, 2024 and 330 shares purchased on November 14, 2024.
- [F3]Reflects an aggregate of 5,871 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 9, 2025.
- [F4]Reflects the closing price of ANIK common stock on March 7, 2025, the trading day prior to which the vesting of RSUs gave rise to tax withholding obligations.
- [F5]Consists of shares transferred by Dr. Blanchard to The Cheryl R. Blanchard Amended and Restated Revocable Trust dated December 19, 2014, of which Dr. Blanchard is a beneficiary and the sole trustee.
- [F6]Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 9, 2024.
Documents
Issuer
Anika Therapeutics, Inc.
CIK 0000898437
Entity typeother
Related Parties
1- filerCIK 0001326530
Filing Metadata
- Form type
- 4
- Filed
- Mar 10, 8:00 PM ET
- Accepted
- Mar 11, 5:17 PM ET
- Size
- 10.4 KB